This company has been marked as potentially delisted and may not be actively trading. Cytori Therapeutics (CYTX) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock CYTX vs. DOMH, FBIO, SABS, CRIS, BOLT, MTEM, AMGN, GILD, VRTX, and REGNShould you be buying Cytori Therapeutics stock or one of its competitors? The main competitors of Cytori Therapeutics include Dominari (DOMH), Fortress Biotech (FBIO), SAB Biotherapeutics (SABS), Curis (CRIS), Bolt Biotherapeutics (BOLT), Molecular Templates (MTEM), Amgen (AMGN), Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), and Regeneron Pharmaceuticals (REGN). These companies are all part of the "biotechnology" industry. Cytori Therapeutics vs. Dominari Fortress Biotech SAB Biotherapeutics Curis Bolt Biotherapeutics Molecular Templates Amgen Gilead Sciences Vertex Pharmaceuticals Regeneron Pharmaceuticals Cytori Therapeutics (NASDAQ:CYTX) and Dominari (NASDAQ:DOMH) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, community ranking, media sentiment, valuation, dividends, profitability, earnings, analyst recommendations and risk. Does the MarketBeat Community prefer CYTX or DOMH? Cytori Therapeutics received 442 more outperform votes than Dominari when rated by MarketBeat users. CompanyUnderperformOutperformCytori TherapeuticsOutperform Votes44273.67% Underperform Votes15826.33% DominariN/AN/A Which has more volatility & risk, CYTX or DOMH? Cytori Therapeutics has a beta of 1.96, indicating that its stock price is 96% more volatile than the S&P 500. Comparatively, Dominari has a beta of 0.86, indicating that its stock price is 14% less volatile than the S&P 500. Which has stronger valuation and earnings, CYTX or DOMH? Cytori Therapeutics has higher earnings, but lower revenue than Dominari. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCytori Therapeutics$3.67M3.93-$12.63MN/AN/ADominari$18.15M4.57-$22.88M-$2.39-2.37 Do institutionals & insiders hold more shares of CYTX or DOMH? 2.6% of Cytori Therapeutics shares are held by institutional investors. Comparatively, 42.5% of Dominari shares are held by institutional investors. 0.7% of Cytori Therapeutics shares are held by company insiders. Comparatively, 33.0% of Dominari shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the media refer more to CYTX or DOMH? In the previous week, Dominari's average media sentiment score of 1.87 beat Cytori Therapeutics' score of 0.00 indicating that Dominari is being referred to more favorably in the news media. Company Overall Sentiment Cytori Therapeutics Neutral Dominari Very Positive Is CYTX or DOMH more profitable? Dominari has a net margin of -180.22% compared to Cytori Therapeutics' net margin of -242.60%. Dominari's return on equity of -32.89% beat Cytori Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Cytori Therapeutics-242.60% -272.70% -56.23% Dominari -180.22%-32.89%-29.47% SummaryDominari beats Cytori Therapeutics on 8 of the 11 factors compared between the two stocks. Get Cytori Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CYTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CYTX vs. The Competition Export to ExcelMetricCytori TherapeuticsSurgical & Medical Instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$14.41M$4.39B$5.55B$8.04BDividend YieldN/A39.93%5.09%4.22%P/E RatioN/A29.8622.6818.83Price / Sales3.9357.90404.28106.72Price / CashN/A51.0838.1834.62Price / Book1.866.226.794.33Net Income-$12.63M$68.15M$3.22B$247.97M Cytori Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CYTXCytori TherapeuticsN/A$0.65-9.6%N/A-58.2%$14.41M$3.67M0.0037DOMHDominari1.077 of 5 stars$4.64-2.5%N/A+119.8%$67.95M$18.15M-1.204Positive NewsFBIOFortress Biotech2.4039 of 5 stars$1.70+0.9%$21.00+1,138.9%+0.6%$50.06M$57.68M-0.56170Positive NewsSABSSAB Biotherapeutics3.3129 of 5 stars$1.76-1.9%$11.40+549.6%-58.7%$16.30M$2.24M-0.48140Short Interest ↓News CoverageGap DownCRISCuris2.5644 of 5 stars$1.80-3.0%$21.00+1,064.1%-84.5%$15.31M$10.91M-0.2360Upcoming EarningsAnalyst ForecastShort Interest ↑Analyst RevisionGap UpBOLTBolt Biotherapeutics2.6682 of 5 stars$0.36-3.3%$1.13+214.2%-68.7%$13.73M$7.69M-0.2190Short Interest ↑Gap UpMTEMMolecular Templates1.1125 of 5 starsN/AN/AN/A$1,000.00$23.48M0.00260AMGNAmgen4.5409 of 5 stars$287.06+1.4%$310.57+8.2%+2.3%$154.35B$33.42B38.0225,200Earnings ReportAnalyst ForecastPositive NewsGap UpGILDGilead Sciences4.7402 of 5 stars$106.25-0.1%$109.43+3.0%+57.6%$132.28B$28.74B287.1217,000Dividend AnnouncementVRTXVertex Pharmaceuticals3.9722 of 5 stars$500.37+0.8%$514.91+2.9%+24.1%$128.80B$11.02B-228.004,800Upcoming EarningsPositive NewsREGNRegeneron Pharmaceuticals4.8421 of 5 stars$565.19-7.5%$945.32+67.3%-34.7%$61.67B$14.20B14.7411,900Earnings ReportDividend AnnouncementAnalyst ForecastAnalyst Revision Related Companies and Tools Related Companies DOMH Competitors FBIO Competitors SABS Competitors CRIS Competitors BOLT Competitors MTEM Competitors AMGN Competitors GILD Competitors VRTX Competitors REGN Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CYTX) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytori Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Cytori Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CYTX Stock Free CYTX Stock Alerts